Head-to-head · Medical Imaging Analytics Software
Us2.ai vs Cancer Imaging Phenomics Toolkit (CaPTk)
Us2.ai leads on 3 checks, Cancer Imaging Phenomics Toolkit (CaPTk) on 1, and 3 are even. Who comes out ahead on the 7 yes/no, price and count checks where we have data for both products. The editor score weighs everything else too.
Our verdict
- Highest scoreUs2.ai · 8.6/10
- Free planonly Cancer Imaging Phenomics Toolkit (CaPTk)
- Free trialonly Us2.ai
- Most featuresUs2.ai · 4 of 6
Us2.ai scores higher on our rubric for medical imaging analytics software: 8.6 against 8.2 out of 10; our editors rank them #5 and #8.
Cancer Imaging Phenomics Toolkit (CaPTk) offers free plan; Us2.ai doesn't. Us2.ai offers ai detection; Cancer Imaging Phenomics Toolkit (CaPTk) doesn't. Us2.ai offers cardiac analytics; Cancer Imaging Phenomics Toolkit (CaPTk) doesn't. Us2.ai offers regulatory clearance; Cancer Imaging Phenomics Toolkit (CaPTk) doesn't. On deployment model, Us2.ai gives you Hybrid where Cancer Imaging Phenomics Toolkit (CaPTk) offers On_premises.
Us2.ai is the better fit for cardiology teams automating echocardiography. Cancer Imaging Phenomics Toolkit (CaPTk) is the better fit for researchers needing free quantitative cancer imaging tools.
- Us2.ai fits best
Cardiology teams automating echocardiography
- Cancer Imaging Phenomics Toolkit (CaPTk) fits best
Researchers needing free quantitative cancer imaging tools
Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.
Side by side
| Feature | Us2.ai 8.6/10 Visit ↗ | Cancer Imaging Phenomics Toolkit (CaPTk) 8.2/10 Visit ↗ |
|---|---|---|
| At a glance | ||
| Editor score | 8.6 | 8.2 |
| Ranking | #5 in Medical Imaging Analytics Software | #8 in Medical Imaging Analytics Software |
| Best for | Cardiology teams automating echocardiography | Researchers needing free quantitative cancer imaging tools |
| Pricing model | Paid | Free |
| Starting price | Pricing on request · 30-day trial | Free plan |
| Free plan | — | ✓ (best) |
| Free trial | 30 days | — |
| Deployment | Cloud, Self-hosted | Desktop, Self-hosted |
| Platforms | Web | Windows, Linux, macOS |
| Support | Email, Docs | Email, Community, Docs |
| Built for | Mid-market, Enterprise | Small business, Mid-market, Enterprise |
| Features Us2.ai 4/6 · Cancer Imaging Phenomics Toolkit (CaPTk) 1/6 | ||
| AI detection | ✓ (best) | — |
| Triage and prioritization | — | — |
| Segmentation & metrics | ✓ | ✓ |
| Cardiac analytics | ✓ (best) | — |
| Pathology analysis | — | — |
| Regulatory clearance | ✓ (best) | — |
| Specs | ||
| Deployment model | Hybrid | On_premises |
| Our review | ||
| Pros |
|
|
| Cons |
|
|
| Our verdict | Us2.ai is a software-as-a-medical-device platform for cardiology teams analyzing transthoracic echocardiogram images. It generates automated cardiac measurements, guideline-based conclusions and structured reports for clinician review. The… Read the review → |
Cancer Imaging Phenomics Toolkit (CaPTk) is a C++ platform from the University of Pennsylvania’s Center for Biomedical Image Computing and Analytics. It targets researchers analyzing radiographic cancer images, with emphasis on brain,… Read the review → |
Strengths and trade-offs
Us2.ai — where it wins
- Automates chamber, systolic, diastolic and strain measurements
- Produces guideline-based reports and disease conclusions
- Supports DICOM, DICOM-SR, HL7, PACS and batch-analysis APIs
Where it doesn't
- Pricing requires contacting sales
- No free plan is offered
- Focused on echocardiography rather than broad imaging workflows
Cancer Imaging Phenomics Toolkit (CaPTk) — where it wins
- Free toolkit covering viewing, preprocessing, segmentation and feature extraction
- Deep-learning segmentation plus machine-learning training and predictive modeling
- Windows, Linux and macOS support with command-line batch workflows
Where it doesn't
- Designed for research and not FDA-approved for clinical use
- Desktop and self-hosted deployment may not fit cloud-first teams
- SBIA/CBICA license is not an OSI open-source license
- Us2.ai8.6/10 · Pricing on request · 30-day trial
A cardiac-focused echo analytics platform with automated measurements, conclusions and structured reports.
Visit Us2.aiFull verdict → - Cancer Imaging Phenomics Toolkit (CaPTk)8.2/10 · Free plan
A free, research-focused toolkit for cancer image segmentation, measurement and modeling.
Visit CaPTkFull verdict →
Us2.ai vs Cancer Imaging Phenomics Toolkit (CaPTk): questions
Which is better for medical imaging analytics software, Us2.ai or Cancer Imaging Phenomics Toolkit (CaPTk)?
Us2.ai scores higher on our rubric for medical imaging analytics software: 8.6 against 8.2 out of 10; our editors rank them #5 and #8.
How do Us2.ai and Cancer Imaging Phenomics Toolkit (CaPTk) compare?
Of the 7 checks we put side by side, Us2.ai leads on 3, Cancer Imaging Phenomics Toolkit (CaPTk) on 1, and 3 are level. Free plan only on Cancer Imaging Phenomics Toolkit (CaPTk).
Do Us2.ai and Cancer Imaging Phenomics Toolkit (CaPTk) have a free plan?
Us2.ai: No. Cancer Imaging Phenomics Toolkit (CaPTk): Yes.
Where do Us2.ai and Cancer Imaging Phenomics Toolkit (CaPTk) rank among medical imaging analytics software?
In our medical imaging analytics software ranking of 54, Us2.ai is #5 and Cancer Imaging Phenomics Toolkit (CaPTk) is #8.
More comparisons
- AI-Rad Companion vs Us2.ai
- AI-Rad Companion vs Cancer Imaging Phenomics Toolkit (CaPTk)
- Aidoc vs Us2.ai
- Aidoc vs Cancer Imaging Phenomics Toolkit (CaPTk)
- Qure.ai vs Us2.ai
- Qure.ai vs Cancer Imaging Phenomics Toolkit (CaPTk)
- Paige vs Us2.ai
- Paige vs Cancer Imaging Phenomics Toolkit (CaPTk)
All medical imaging analytics software comparisons → · Full ranking →
Reviewed by iTechGuides Editors · Editorial team · Updated Nov 2026
Last updated · How we research and update